Optum Rx launches fee-based pharmacy benefit pricing model
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
May 11, 2026 4:30 PM EDTMarket-leading approach to client and consumer transparency further aligns incentives across patients and plan sponsors, offering consumers new affordability tools
Today, Optum Rx announced a new pharmacy care model that fundamentally changes how pharmacy benefits are priced and delivered replacing traditional approaches tied to drug prices set by manufacturers or prescription volume with a transparent, feebased structure offered to every Optum Rx PBM customer. The model is designed to fully align incentives with patients and plan sponsors, bringing greater clarity, predictability and affordability to pharmacy care supported by digital capabilities that help patients better understand costs and make... More
